千红制药：向不特定对象发行可转换公司债券申请获得深交所受理

Group 1 - The company received a notification from the Shenzhen Stock Exchange on January 23, 2026, regarding the acceptance of its application for issuing convertible bonds to unspecified objects [1] - The Shenzhen Stock Exchange has verified that the application documents for the issuance of convertible bonds are complete and has decided to accept the application [1] - The issuance of convertible bonds is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval process and timeline [1]